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Sequencing Instrument 
Illumina NextSeq 500 System 
A Plant-Derived Steroidal Alkaloid Potentially Targets the Fungal Cell Wall 
Sample Preparation 
RNA-Seq Technology 
Prepare cDNA from mRNA 
A Microbe-Derived Cyclic Peptide Potentially Targets Fungal Calcium Homeostasis 


















































































Functional Categorization of 252 Genes Upregulated by Compound 1 
Functional Categorization of 290 Genes Upregulated by Compound 2 
Compound 1 Response is Similar to Response of Cell Wall Targeting Drug Caspofungin 
Compound 2 Response is Similar to Increased Calcium Response 
Significance: 
- Caspofungin is only effective against Candida species, not against Cryptococcus species. 
- Compound 1 has very potent activity against Cryptococcus species. 
- Cell wall targeting antifungals are fungal specific and less toxic. 
Significance: 
- Current antifungal drugs don’t target calcium homeostasis. 
- Calcium plays important roles in virulence of fungal pathogens. 
GOID GO_term Cluster frequency Background frequency P-value
71554 cell wall organization or biogenesis 35 out of 252 genes, 13.9% 198 out of 7165 background genes, 2.8% 6.22E-13
5975 carbohydrate metabolic process 30 out of 252 genes, 11.9% 221 out of 7165 background genes, 3.1% 9.23E-08
9628 response to abiotic stimulus 19 out of 252 genes, 7.5% 172 out of 7165 background genes, 2.4% 0.00649
GOID GO term Frequency Genome Frequency
8150  biological process unknown 77 out of 290 genes, 26.6% 1133 of 6433 genes, 17.6%
71554  cell wall organization or biogenesis32 out of 290 genes, 11.0% 198 of 6433 genes, 3.1%
42221  response to chemical 29 out of 290 genes, 10% 446 of 6433 genes, 6.9%
5975  carbohydrate metabolic process 21 out of 290 genes, 7.2% 198 of 6433 genes, 3.1%
6811  ion transport 20 out of 290 genes, 6.9% 263 of 6433 genes, 4.1%
6629  lipid metabolic process 19 out of 290 genes, 6.6% 296 of 6433 genes, 4.6%
43934  sporulation 17 out of 290 genes, 5.9% 133 of 6433 genes, 2.1%
6605  protein targeting 16 out of 290 genes, 5.5% 307 of 6433 genes, 4.8%
51321  meiotic cell cycle 16 out of 290 genes, 5.5% 282 of 6433 genes, 4.4%
55085  transmembrane transport 14 out of 290 genes, 4.8% 234 of 6433 genes, 3.6%
23052  signaling 14 out of 290 genes, 4.8% 245 of 6433 genes, 3.8%
6468  protein phosphorylation 12 out of 290 genes, 4.1% 197 of 6433 genes, 3.1%
DMSO (0.25%) Compound (IC50 conc.) 
Drug treatment of yeast cells for 1.5 doublings (~ 4.5 h) 
Isolate RNA 
Perform RNA sequencing 
ID differentially expressed genes 
Prepare sequencing library 
Experimental Strategy 
From Wertheim, B. (2012) Beyond the gene list: Exploring transcriptomics data in search of gene functions, trait mechanisms, and genetic architecture. 
In “Functional Genomics”, ed. Meroni, G., InTech, DOI: 10.5772/48239. 
